Pharmacological management of the agitated pediatric patient

Andrea J Adimando1, Yann B Poncin, Carl R Baum

  • 1Yale-New Haven Children's Hospital, New Haven, CT, USA.

Pediatric Emergency Care
|November 9, 2010
PubMed

Insights

Pediatric emergency departments frequently encounter agitated children. Recognizing risk factors and timely assessment are crucial for safe and effective management, often involving medication.

Area of Science:

  • Pediatric Emergency Medicine
  • Child Psychiatry
  • Behavioral Pediatrics

Background:

  • Children with behavioral or psychiatric issues are often seen in pediatric emergency rooms.
  • Agitation or violence can occur during evaluation, posing challenges for staff.
  • Effective management strategies are needed for patient and staff safety.

Purpose of the Study:

  • To highlight the importance of recognizing risk factors for agitation in pediatric emergency settings.
  • To emphasize the need for timely assessment of agitated pediatric patients.
  • To discuss the role of pharmacological interventions in managing pediatric agitation.

Main Methods:

  • Review of existing literature on pediatric agitation in emergency departments.
  • Analysis of risk factors associated with behavioral emergencies in children.
  • Discussion of current management approaches, including pharmacological options.

Main Results:

  • Agitation is a common presentation in pediatric emergency evaluations.
  • Awareness of risk factors aids in proactive patient assessment.
  • Pharmacological agents can be safely and effectively used to manage agitation.

Conclusions:

  • Pediatric emergency practitioners must be prepared to manage agitated children.
  • Timely assessment and appropriate interventions, including medication, are key to positive outcomes.
  • Ensuring safety for both patients and staff is paramount in managing behavioral emergencies.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...